EP 4164640 A1 20230419 - METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH BERBERINE, A BERBERIDACEAEN ALKALOID, AND DERIVATIVES THEREOF
Title (en)
METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH BERBERINE, A BERBERIDACEAEN ALKALOID, AND DERIVATIVES THEREOF
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON MYOPIE MIT BERBERIN, EINEM BERBERIDACEN-ALKALOID UND DERIVATEN DAVON
Title (fr)
MÉTHODES ET COMPOSITIONS POUR PRÉVENIR ET TRAITER LA MYOPIE AVEC DE LA BERBÉRINE, UN ALCALOÏDE DE BERBÉRIDACÉE, ET DES DÉRIVÉS DE CELLE-CI
Publication
Application
Priority
- US 202063037918 P 20200611
- US 2021036738 W 20210610
Abstract (en)
[origin: WO2021252717A1] The disclosure relates to methods and compositions for preventing and/or treating an ocular disease. In particular, the disclosure relates to preventing and/or treating myopia with systemic or topical administration of berberine chloride, which is a berberidaceaen alkaloid, or a derivative thereof.
IPC 8 full level
A61K 31/4375 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01)
CPC (source: EP IL KR)
A61K 9/0048 (2013.01 - EP IL KR); A61K 9/0053 (2013.01 - EP IL); A61K 31/4375 (2013.01 - EP IL KR); A61P 27/10 (2018.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021252717 A1 20211216; CA 3182437 A1 20211216; CN 116056727 A 20230502; EP 4164640 A1 20230419; EP 4164640 A4 20240717; IL 299009 A 20230201; JP 2023529945 A 20230712; KR 20230051155 A 20230417
DOCDB simple family (application)
US 2021036738 W 20210610; CA 3182437 A 20210610; CN 202180057520 A 20210610; EP 21821521 A 20210610; IL 29900922 A 20221211; JP 2022576492 A 20210610; KR 20237001146 A 20210610